LGP's NEW Medical Portal
15 Mar 2021
The Therapeutic Goods Administration (TGA), has set its largest month on record for Medicinal cannabis approvals.
The TGA has published its February figures for SAS category B approvals setting another milestone with 8057 patients approved for medicinal cannabis. This is yet another strong month showing continuous demand for medicinal cannabis products. As of the 28th of February 2020, the TGA has approved nearly 100,000 SAS category B Applications for unapproved medical cannabis products (TGA: SAS Category B approval statistics).
Please note: these numbers do not include patients accessing medicinal cannabis via clinical trials or via Authorised Prescribers (medical practitioners who are approved to prescribe medical cannabis without needing to wait for patient approval from the TGA). There are now 215 Authorised Prescribers in Australia (TGA: SAS Category B approval statistics).
Little Green Pharma is also sponsoring a medicinal cannabis study looking at the impact of quality of life across a range of chronic health conditions. If you want to learn more about this study and how to access discounted medication please visit: theQuestinitiative
Australia's latest listed medicinal cannabis company has launched onto the market with a bang, scoring a major UK distribution deal the night before landing.
Little Green Pharma have sponsored a new digital platform, GreenChoices to provide both medical practitioners and patients with meaningful research and education, with the aim of assisting them make informed choices about medical cannabis as a possible treatment option.